[1] 徐如祥,赵浩.急性缺血性脑卒中溶栓治疗展望[J].中华神经医学杂志,2018,17(2):114-116. [2] 李华,梁维,余振威.急性缺血性脑卒中静脉溶栓预后的影响因素分析[J].中国实用神经疾病杂志,2018,21(1):34-36. [3] 中国中西医结合学会急救医学专业委员会.中国急性缺血性脑卒中中西医急诊诊治专家共识[J].中华危重病急救医学,2018,30(3):193-197. [4] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257. [5] 赵明艳,刘舒,李永秋.老年急性缺血性脑卒中患者早期神经功能恶化的影响因素[J].中国老年学杂志,2018,38(6):1321-1324. [6] 郝云飞,陈合成,李小丽, 等.rtPA静脉溶栓桥接血管内治疗急性缺血性脑卒中临床观察[J].中国实用神经疾病杂志,2018,21(5):475-478. [7] Van Hooff RJ,Nieboer K,De Smedt A,et al.Validation assessment of risk tools to predict outcome After thrombolytic therapy for acute ischemic stroke[J].Clin Neurol Neurosurg,2014,125:189-193. [8] Asuzu D,Nystrom K,Amin H,et al.Comparison of 8 scores for predicting symptomatic intracerebral hemorrhage after IV thrombolysis[J].Neurocrit Care,2015,22(2):229-233. [9] Zhang XM,Wang CJ,Liao XL,et al.Review of prognosis in acute stroke Patients treated with thrombolysis[J].Chin J Stroke,2014,9(12):1041-1047. [10] Saposnik G, Demchuk A, Tu JV,et al. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological Disorders and Stroke Tissue Plasminogen Activator Stroke Trial[J].J Stroke Cerebrovasc Dis,2013,22(6):876-882. [11] Strbian D, Engelter S, Michel P, et al. Symptomatic intracranial hemorrhage after stroke thrombolysis:the SEDAN score[J].Ann Neurol,2012, 71(5):634-641. [12] Mazya M, Egido JA, Ford GA, et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase:Safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score[J].Stroke,2012,43(6):1524-1531.
2019, Vol. 36 
